These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma. Iasonos A; Keung EZ; Zivanovic O; Mancari R; Peiretti M; Nucci M; George S; Colombo N; Carinelli S; Hensley ML; Raut CP Cancer; 2013 May; 119(10):1816-22. PubMed ID: 23456762 [TBL] [Abstract][Full Text] [Related]
10. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260 [TBL] [Abstract][Full Text] [Related]
11. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma. Rauh-Hain JA; Hinchcliff EM; Oduyebo T; Worley MJ; Andrade CA; Schorge JO; George S; Muto MG; del Carmen MG Int J Gynecol Cancer; 2014 Oct; 24(8):1434-40. PubMed ID: 25248114 [TBL] [Abstract][Full Text] [Related]
13. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease. Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425 [TBL] [Abstract][Full Text] [Related]
14. Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results. Sugarbaker P; Ihemelandu C; Bijelic L Ann Surg Oncol; 2016 May; 23(5):1501-7. PubMed ID: 26545375 [TBL] [Abstract][Full Text] [Related]
15. Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis. Leitao MM; Zivanovic O; Chi DS; Hensley ML; O'Cearbhaill R; Soslow RA; Barakat RR Gynecol Oncol; 2012 May; 125(2):409-13. PubMed ID: 22366592 [TBL] [Abstract][Full Text] [Related]
16. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. Bogani G; Cliby WA; Aletti GD Gynecol Oncol; 2015 Apr; 137(1):167-72. PubMed ID: 25462199 [TBL] [Abstract][Full Text] [Related]
17. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand. Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003. Ayhan A; Gungorduk K; Khatib G; Fırat Cüylan Z; Boran N; Gökçü M; Çelik H; Özgül N; Akbayir Ö; Şimşek T; Bakay A; Faruk Köse M; Tunç M; Küçükgöz Güleç Ü; Koç S; Kuşçu E; Vardar MA; Akilli H; Taskiran C; Mutlu Meydanlı M Curr Probl Cancer; 2021 Oct; 45(5):100712. PubMed ID: 33685725 [TBL] [Abstract][Full Text] [Related]
19. Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma. Takehara K; Yamashita N; Watanabe R; Teramoto N; Tsuda H; Motohashi T; Harano K; Nakanishi T; Tokunaga H; Susumu N; Ueda Y; Yokoyama Y; Saito T Gynecol Oncol; 2020 Apr; 157(1):115-120. PubMed ID: 31983515 [TBL] [Abstract][Full Text] [Related]
20. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome. Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]